default author photo

Prescott G. Woodruff

University of California, San Francisco (UCSF) - Division of Pulmonary, Critical Care, Allergy and Sleep Medicine

San Francisco General Hospital

Box 2911

San Francisco, CA

United States

Genentech, Inc. - San Francisco - Antibody Engineering

1 DNA Way

San Francisco, CA

United States

SCHOLARLY PAPERS

3

DOWNLOADS

195

TOTAL CITATIONS

1

Scholarly Papers (3)

1.

Systemic Biomarkers of Lung Function and FEV 1 Decline Across Multiple Cohorts

Number of pages: 42 Posted: 20 Oct 2020
Harvard University - Cardiovascular Research Institute, National Jewish Health, Helmholtz Association of German Research Centres - German Research Centre for Environmental Health, Lovelace Respiratory Research Institute, University of North Carolina (UNC) at Chapel Hill - Department of Pathology and Laboratory Medicine, University of Virginia - Center for Public Health Genomics, Harvard University - Cardiovascular Research Institute, Harvard University - Cardiovascular Research Institute, Harvard University - Cardiovascular Research Institute, National Jewish Health, Boston University School of Public Health - Department of Biostatistics, AstraZeneca - Translational Science and Experimental Medicine, Helmholtz Association of German Research Centres - German Research Centre for Environmental Health, Weill Cornell Medicine in Qatar - Department of Physiology and Biophysics, Max Planck Institute for Heart and Lung Research - Biomolecular Mass Spectrometry, University of Washington - Department of Biostatistics, University of Washington - Department of Biostatistics, University of Vermont - Department of Pathology and Laboratory Medicine, UCLA Medical Center - The Institute for Translational Genomics and Population Sciences, Duke University - Duke Molecular Physiology Institute, University of Washington - Department of Biostatistics, University of Vermont - Department of Pathology and Laboratory Medicine, University of Vermont - Department of Pathology and Laboratory Medicine, UCLA Medical Center - The Institute for Translational Genomics and Population Sciences, Government of the United States of America - National Heart, Lung and Blood Institute, University of Virginia - Center for Public Health Genomics, UCLA Medical Center - The Institute for Translational Genomics and Population Sciences, University of Nebraska at Omaha, University of Michigan at Ann Arbor, University of California, San Francisco (UCSF) - Division of Pulmonary, Critical Care, Allergy and Sleep Medicine, University of Iowa, Carver College of Medicine, Department of Internal Medicine, Harvard University - Channing Division of Network Medicine, National Jewish Health, Boston University School of Public Health - Department of Biostatistics, Boston University - Preventive Medicine and Epidemiology, University of Texas Southwestern Medical Center - Department of Medicine, Beth Israel Deaconess Medical Center - Division of Cardiovascular Medicine, Boston University - Chobanian & Avedisian School of Medicine, Columbia University - Irving Medical Center, University of North Carolina (UNC) at Chapel Hill - Department of Biostatistics, Boston University - Department of Biostatistics, University of Virginia - Center for Public Health Genomics, University of North Carolina (UNC) at Chapel Hill, Harvard University - Division of Pulmonary and Critical Care Medicine, Helmholtz Association of German Research Centres - German Research Centre for Environmental Health and National Jewish Health - Department of Medicine
Downloads 109 (659,652)

Abstract:

Loading...

biomarker, lung function, FEV1 decline, Proteomics

2.

An Allosteric Anti-Tryptase Antibody for the Treatment of Mast Cell-Mediated Severe Asthma

Number of pages: 64 Posted: 03 Mar 2019 Last Revised: 07 Oct 2019
Genentech, Inc. - San Francisco - Departments of Early Discovery Biochemistry, Genentech, Inc. - San Francisco - Department of Discovery Immunology, Genentech, Inc. - San Francisco - Biomarker Discovery OMNI, Genentech, Inc. - San Francisco - Biochemical and Cellular Pharmacology, Genentech, Inc. - San Francisco - Biomarker Discovery OMNI, Genentech, Inc. - San Francisco - Human Genetics, Genentech, Inc. - San Francisco - Bioinformatics, Genentech, Inc. - San Francisco - OMNI Biomarker Development, Genentech, Inc. - San Francisco - Biochemical and Cellular Pharmacology, Genentech, Inc. - San Francisco - Antibody Engineering, Genentech, Inc. - San Francisco - Antibody Engineering, University of California, San Francisco (UCSF), School of Medicine, Department of Medicine, Genentech, Inc. - San Francisco - Biochemical and Cellular Pharmacology, Genentech, Inc. - San Francisco - Departments of Early Discovery Biochemistry, Genentech, Inc. - San Francisco - Biomolecular Resources, Genentech, Inc. - San Francisco - Translational Immunology, Genentech, Inc. - San Francisco - Translational Immunology, Genentech, Inc. - San Francisco - Structural Biology, Genentech, Inc. - San Francisco - Human Genetics, Genentech, Inc. - San Francisco - Human Genetics, Genentech, Inc. - San Francisco - Biomolecular Resources, Genentech, Inc. - San Francisco - Protein Chemistry, Genentech, Inc. - San Francisco - Protein Chemistry, Genentech, Inc. - San Francisco - Protein Chemistry, Genentech, Inc. - San Francisco - Protein Chemistry, Genentech, Inc. - San Francisco - Preclinical and Translational Pharmacokinetics, Genentech, Inc. - San Francisco - Preclinical and Translational Pharmacokinetics, Genentech, Inc. - San Francisco - OMNI Biomarker Development, Virginia Commonwealth University (VCU), School of Medicine, Division of Rheumatology, Allergy and Immunology, Department of Internal Medicine, Charité - Universitätsmedizin Berlin - Department of Dermatology and Allergy, University of California, San Francisco (UCSF) - Division of Pulmonary, Critical Care, Allergy and Sleep Medicine, Genentech, Inc. - San Francisco - Antibody Engineering, Genentech, Inc. - San Francisco - Antibody Engineering, Genentech, Inc. - San Francisco - Antibody Engineering, Genentech, Inc. - San Francisco - Safety Assessment, Genentech, Inc. - San Francisco - Safety Assessment, Genentech, Inc. - San Francisco - OMNI Biomarker Development, Genentech, Inc. - San Francisco - Translational Immunology, Genentech, Inc. - San Francisco - Departments of Early Discovery Biochemistry, Genentech, Inc. - San Francisco - Department of Discovery Immunology, Genentech, Inc. - San Francisco - OMNI Biomarker Development, Genentech, Inc. - San Francisco - Bioinformatics, Genentech, Inc. - San Francisco - Structural Biology, Genentech, Inc. - San Francisco - Department of Discovery Immunology, Genentech, Inc. - San Francisco - Departments of Early Discovery Biochemistry and Genentech, Inc. - San Francisco - Department of Discovery Immunology
Downloads 54 (1,031,043)

Abstract:

Loading...

3.

Large Differences in Small RNA Composition Between Human Biofluids

Number of pages: 47 Posted: 06 Apr 2018
University of California, San Francisco (UCSF) - Lung Biology Center, University of California, San Francisco (UCSF) - Division of Pulmonary, Critical Care, Allergy and Sleep Medicine, University of California, San Francisco (UCSF) - Lung Biology Center, University of California, San Francisco (UCSF) - Department of Obstetrics, Gynecology and Reproductive Sciences, University of California, San Francisco (UCSF) - Department of Obstetrics, Gynecology and Reproductive Sciences, University of California, San Francisco (UCSF) - Department of Orthopaedic Surgery, Mayo Clinic - Florida - Transplant Center, University of California, San Francisco (UCSF) - Department of Neurology, University of California, San Francisco (UCSF) - Department of Urology, University of California, San Francisco (UCSF) - Division of Pulmonary, Critical Care, Allergy and Sleep Medicine and University of California, San Francisco (UCSF) - UCSF CoLabs
Downloads 32 (1,304,549)
Citation 1

Abstract:

Loading...